Dr. Martens (LON:DOCS) Stock Price Down 9.6% – What’s Next?

Dr. Martens plc (LON:DOCS)’s stock price fell 9.6% during trading on Thursday . The company traded as low as GBX 72.30 and last traded at GBX 73.80. 4,733,644 shares were traded during mid-day trading, an increase of 115% from the average session volume of 2,203,986 shares. The stock had previously closed at GBX 81.60.

Wall Street Analysts Forecast Growth

Separately, Peel Hunt reissued a “buy” rating on shares of Dr. Martens in a report on Thursday. One research analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat, Dr. Martens currently has an average rating of “Hold” and a consensus price target of GBX 6,000.

Dr. Martens Stock Performance

The company has a debt-to-equity ratio of 127.27, a quick ratio of 1.13 and a current ratio of 2.85. The firm has a market cap of £713.15 million, a P/E ratio of 147.60, a PEG ratio of 6.40 and a beta of 0.11. The stock’s 50-day moving average is GBX 90.64 and its 200 day moving average is GBX 80.35.

Dr. Martens (LON:DOCS) last released its quarterly earnings results on Thursday, November 20th. The company reported GBX (0.90) earnings per share (EPS) for the quarter. Dr. Martens had a net margin of 7.89% and a return on equity of 18.91%. On average, research analysts predict that Dr. Martens plc will post 2.5809394 earnings per share for the current year.

Insider Buying and Selling

In other Dr. Martens news, insider Ije Nwokori sold 298,675 shares of the stock in a transaction on Wednesday, October 15th. The stock was sold at an average price of GBX 90, for a total transaction of £268,807.50. Also, insider Giles Wilson acquired 105,838 shares of the company’s stock in a transaction on Monday, September 1st. The stock was acquired at an average price of GBX 91 per share, with a total value of £96,312.58. Over the last three months, insiders have purchased 136,960 shares of company stock worth $12,460,163 and have sold 434,460 shares worth $39,131,400. 2.80% of the stock is currently owned by insiders.

Dr. Martens Company Profile

Founded in 1960, Dr. Martens is an iconic British brand with a global presence. “Docs” or “DMs” were originally
produced for their durability for workers, before being adopted by diverse youth subcultures and associated musical
movements. Today, Dr. Martens has transcended its roots while still celebrating its proud history.